Not applicableUnknownNCT05806151What this trial is testingPrediction of True Oligo-metastatic Disease.Who this might be right forOligometastatic Disease National Cancer Institute, Naples 32
Not applicableStudy completedNCT07446946What this trial is testingSurgical Management of Pancreatic Cancer With Liver Metastasis (Oligometastasis)Who this might be right forPancreatic Cancer With Liver Metastases Richard Hunger 68,303
Not applicableLooking for participantsNCT06668454What this trial is testingChemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)Who this might be right forEsophageal CancerGastric CancerOligometastatic Disease University Health Network, Toronto 72
Testing effectiveness (Phase 2)Looking for participantsNCT07269626What this trial is testingPULSAR in Systemic Therapy for Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma Samsung Medical Center 47
Testing effectiveness (Phase 2)Study completedNCT04821765What this trial is testingStudy of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal CancerWho this might be right forEsophagus CancerChemoradiotherapyOligometastatic Disease+1 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 35
Not applicableLooking for participantsNCT07697859What this trial is testingPD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCCWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Fudan University 354
Testing effectiveness (Phase 2)Looking for participantsNCT07455019What this trial is testingBemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal CancerWho this might be right forEsophageal Cancer The First Affiliated Hospital with Nanjing Medical University 28
Not applicableLooking for participantsNCT04498767What this trial is testingStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)Who this might be right forGynecologic CancerSkin CancerHead and Neck Cancer+12 more European Organisation for Research and Treatment of Cancer - EORTC 200